Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
life sciences
national blog main
7
×
san francisco top stories
san francisco blog main
biotech
boston blog main
fda
national top stories
boston top stories
indiana blog main
indiana top stories
new york top stories
raleigh-durham blog main
san diego blog main
san diego top stories
boulder/denver blog main
boulder/denver top stories
clinical trials
detroit blog main
detroit top stories
national
new york blog main
raleigh-durham top stories
san francisco
seattle blog main
seattle top stories
texas blog main
texas top stories
wisconsin blog main
wisconsin top stories
alnylam pharmaceuticals
deals
drug prices
europe top stories
gene therapy
genentech
novartis
roche
startups
2019
What
drug
7
×
therapy
7
×
fda
approval
patients
approved
bio
developers
disease
friday
gene
oral
roundup
therapeutics
treat
address
advanced
agency
aimmune
allergy
alnylam’s
approves
aren’t
atrophy
awarded
bff
blueprint
building
cancer
carries
certain
conference
daily
daunting
deal
deals
designed
developed
developer
devoted
Language
unset
Current search:
therapy
×
drug
×
" national blog main "
×
@xconomy.com
3 years ago
FDA Approves Blueprint Cancer Drug Targeting RET Genetic Signatures
@xconomy.com
3 years ago
FDA Green-Lights Roche Spinal Muscular Atrophy Drug, First Oral Therapy
@xconomy.com
4 years ago
Aimmune Awarded First FDA Approval for a Peanut Allergy Therapy
@xconomy.com
5 years ago
Bio Roundup: EASL Does It, Alnylam’s BFF, Gene Therapy Deals & More
@xconomy.com
5 years ago
Bio Roundup: Medicare Drug Prices, FDA Moves, Gene Therapy News & More
@xconomy.com
5 years ago
Virtual Physical Therapy Firms Reflexion and MindMaze Probe Markets
@xconomy.com
6 years ago
United Therapeutics Reaches $141M Deal for PAH Drug Firm SteadyMed